Recursion Pharmaceuticals, Inc. (RXRX)
3.75
+0.21
(+5.93%)
USD |
NASDAQ |
Apr 15, 16:00
3.80
+0.05
(+1.33%)
Pre-Market: 09:07
Recursion Pharmaceuticals Shareholders Equity (Quarterly) : 1.131B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 671.39M |
| Tango Therapeutics, Inc. | 346.18M |
| Geron Corp. | 225.87M |
| Ionis Pharmaceuticals, Inc. | 489.09M |
| Quince Therapeutics, Inc. | -35.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.528B |
| Total Liabilities (Quarterly) | 397.49M |
| Debt to Equity Ratio | 0.0689 |
| Current Ratio | 5.503 |
| Net Debt Paydown Yield | 0.12% |